• Extendicare’s third-quarter 2026 revenue rose 42.6% to $627.8 million.
• Adjusted EBITDA increased 41.2% to $71.7 million; excluding out-of-period items, it rose 47.7% to $69.2 million.
• Net earnings climbed 41.8% to $34.2 million.
• Home health care average daily volume surged 111.5% to 79,557, driven by acquisitions and organic growth.
• CBI Home Health contributed $153.3 million in revenue; pro forma debt to adjusted EBITDA improved to approximately 2.3 times.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extendicare Inc. published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.